Boston, MA, United States of America

Gerburg Wulf

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerburg Wulf. Retrieved from https://idiyas.com/inventor/gerburg-wulf-82knf8km

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerburg Wulf: Cancer Research and Patent Innovation.

Introduction

Gerburg Wulf is a woman inventor associated with Boston, Massachusetts, and Dana-Farber Cancer Institute, Inc. Her patent work concerns potential approaches to targeting Pin1, an enzyme studied in cancer research.

Latest Patents

Wulf is associated with 1 patent: “Inhibitors of the Peptidyl-Prolyl Cis/Trans Isomerase (Pin1), Combinations and Uses Thereof.” The patent describes Pin1 inhibitors and their potential use in combination with other treatments.

Career Highlights

Wulf’s listed invention reflects the connection between biomedical research and intellectual property development at Dana-Farber Cancer Institute. The patent focuses on a research area relevant to investigating cancer therapies.

Collaborations

The listed collaborators include Shizhong Ke and Xiao Zhen Zhou. Their association with the patent reflects collaborative work on Pin1 inhibitors and their potential applications.

Conclusion

Gerburg Wulf’s patent activity highlights a contribution to cancer-related innovation through research on Pin1 inhibitors and their potential therapeutic uses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…